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Background: Hypoxia is a major driving force in vascularization and vascular remodeling. Pharmacological inhibition
of prolyl hydroxylases (PHDs) leads to an oxygen-independent and long-lasting activation of hypoxia-inducible
factors (HIFs). Whereas effects of HIF-stabilization on transcriptional responses have been thoroughly investigated in
endothelial cells, the molecular details of cytoskeletal changes elicited by PHD-inhibition remain largely unknown.
To investigate this important aspect of PHD-inhibition, we used a spheroid-on-matrix cell culture model.
Results: Microvascular endothelial cells (glEND.2) were organized into spheroids. Migration of cells from the spheroids
was quantified and analyzed by immunocytochemistry. The PHD inhibitor dimethyloxalyl glycine (DMOG) induced
F-actin stress fiber formation in migrating cells, but only weakly affected microvascular endothelial cells firmly attached
in a monolayer. Compared to control spheroids, the residual spheroids were larger upon PHD inhibition and contained
more cells with tight VE-cadherin positive cell-cell contacts. Morphological alterations were dependent on stabilization
of HIF-1α and not HIF-2α as shown in cells with stable knockdown of HIF-α isoforms. DMOG-treated endothelial cells
exhibited a reduction of immunoreactive Rac-1 at the migrating front, concomitant with a diminished Rac-1 activity,
whereas total Rac-1 protein remained unchanged. Two chemically distinct Rac-1 inhibitors mimicked the effects of
DMOG in terms of F-actin fiber formation and orientation, as well as stabilization of residual spheroids. Furthermore,
phosphorylation of p21-activated kinase PAK downstream of Rac-1 was reduced by DMOG in a HIF-1α-dependent
manner. Stabilization of cell-cell contacts associated with decreased Rac-1 activity was also confirmed in human
umbilical vein endothelial cells.
Conclusions: Our data demonstrates that PHD inhibition induces HIF-1α-dependent cytoskeletal remodeling in
endothelial cells, which is mediated essentially by a reduction in Rac-1 signaling.
Keywords: Hypoxia-inducible transcription factor, endothelial cell, cytoskeleton, migration, Rho kinase, Rac-1,
p21-activated kinase, prolyl hydroxylase inhibitor, von Hippel-Lindau protein, oxygenIntroduction
Hypoxia is a major driving force in vascularization and vas-
cular remodeling [1]. Many of the genes involved in the
regulation of vascular homeostasis are direct or indirect tar-
gets of hypoxia-induced transcription factors (HIFs) known
as crucial mediators of the cellular response to hypoxia [2,3].
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distribution, and reproduction in any mediumthe constitutive non-oxygen-responsive subunit HIF-1β,
and one of either hypoxia-inducible α-subunits, HIF-1α or
HIF-2α [4]. HIF-α subunits are rapidly degraded in
normoxia but highly stabilized by hypoxia. In normoxia,
two prolyl residues of the HIF-α subunits are hydroxylated
by prolyl hydroxylase domain enzymes (PHDs), which be-
long to the group of iron- and 2-oxoglutarate-dependent
oxygenases [5]. This modification is the prerequisite for
binding of the von Hippel-Lindau tumor suppressor pro-
tein (pVHL), which targets HIF-α for proteasomal degrad-
ation. Genetic studies in mice have shown that deletion ofntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Weidemann et al. Cell Communication and Signaling 2013, 11:80 Page 2 of 16
http://www.biosignaling.com/content/11/1/80Vhl in various tissues leads to a pathologically altered vas-
cular phenotype through the constitutive activation of the
hypoxia response pathway [6]. In contrast, partial inhib-
ition of HIF degradation in heterozygous PHD2 deficient
mice led to normalization of endothelial lining and vessel
maturation in tumor vessels [7].
Angiogenesis as a response to activation of HIF tran-
scription factors has been investigated in many studies
related to tumor vascularization (for review see [1,8,9])
but also in context of atherosclerosis [10], or wound
healing [11]. Accordingly, inhibition of PHDs by small
molecules as a way to target remodeling of the vascula-
ture has recently attracted increasing attention [12-14].
Various preclinical studies showed promising effects of
PHD inhibitors: in a mouse model of skeletal trauma,
PHD inhibition increased vascularity and subsequently
callus formation [15]. After myocardial infarction, inhib-
ition of PHDs improved microvascular density in the
periinfarct region [16], which was also observed in the
ischemic brain of mice treated with dimethyloxalyl glycine
(DMOG) following experimental stroke [17]. PHD inhibi-
tors increased endothelial cell migration from spheroids in
three dimensional collagen gels in vitro [18,19] or in angio-
genesis assays such as the sponge model [15,20]. However,
apart from HIF-dependent transcriptional regulation of an-
giogenic factors, molecular effects of PHD inhibition on
the vasculature have not been studied extensively.
Vascular remodeling implies reorganization of the actin
cytoskeleton of endothelial cells [21]. Small GTPases of
the Rho family are major regulators of the actin cytoskel-
eton, and vascular permeability has been shown to be con-
trolled by Rho family proteins, particularly RhoA and
Rac1 [22,23]. Activation of Rac1 was linked to HIF-1α
activation and stabilization in endothelial cells [24,25]
and vascular smooth muscle cells [26]. By contrast, little is
known about HIF-induced alterations in GTPase-mediated
remodeling of actin filaments in endothelial cells. Transi-
ent alterations in F-actin fibers were observed within 1 h
of exposure to hypoxia in pulmonary endothelial cells,
which reverted to normal after 2 h [27] or even decreased
compared to cells cultured in normoxia [28]. Long term
activation of HIF as achieved by pharmacological inhibition
of PHDs has not yet been studied in endothelial cells in
terms of actin remodeling.
In this study, we addressed the question of how inhibition
of PHDs by DMOG affects actin cytoskeletal organization
in microvascular endothelial cells. In an earlier study, we
had observed that renal microvascular endothelial cells
(glEND.2) seeded on glass plates or matrix coated surfaces
hardly migrated in conventional barrier or scratch assays
[19]. Therefore, we modified the model system and orga-
nized the cells into spheroids, which were then plated on
matrix-coated plates, where the cells migrated off the
spheroids within 24 h. This model system addressed twoaspects of endothelial cell interactions: three dimensional
homotypic cell-cell interactions within the spheroids, and
cell-matrix interactions upon migration.
By using this system, we show that inhibition of PHDs by
DMOG increased cell-cell attachment within the spheroids
and strengthened F-actin stress fibers in migrating endo-
thelial cells outside the spheroids. Using stable HIF-1α- or
HIF-2α-deficient glomerular endothelial cells, we demon-
strate that cytoskeletal alterations by PHD inhibition are
HIF-1α dependent. DMOG modulated the subcellular
localization of Rac-1 and activation of its downstream tar-
get p21-activated kinase (PAK). Taken together, our data
provides the first evidence of a link between pharmaco-
logical inhibition of PHDs and cytoskeletal rearrangement
and migration of endothelial cells.
Results
DMOG modulates endothelial migration and cell-cell
contacts within spheroids
Murine glomerular microvascular endothelial cells (cell line
glEND.2) were organized into spheroids overnight and
were then plated on glass plates coated with collagen IV in
the presence or absence of the PHD inhibitor DMOG,
which leads to the stabilization of HIF-α transcription fac-
tors. Approximately 5 h after adherence, cells started to mi-
grate radially from the spheroids. Most of the cells
migrated as a cohort with only few cells loosing contact
(Figure 1A). Movement of the cells was monitored using
live cell imaging. DMOG-treated cells moved in a direc-
tional fashion and extended large protrusions, whereas pro-
trusions were much smaller in control cells, which closely
interacted with each other and even crawled below each
other thus appearing more motile (Additional file 1).
Staining of F-actin fibers with PromoFluor phalloidin
allowed quantification of the area covered by cells still or-
ganized in residual spheroids as well as the area covered
by migrating cells. The number of migrated cells was de-
termined after nuclear staining with DAPI. After 24 h, the
size of the residual spheroids (RS) of DMOG-treated cells
was significantly larger than that of control cells (Figure
1B). Correspondingly, the number of cells which had
migrated from the spheroids was markedly reduced. How-
ever, the area covered by the cohesively migrating cells
was comparable under both conditions, indicative of a lar-
ger area covered by individual cells in the DMOG group.
A comparable effect was observed when endothelial cells
were plated in a cell culture dish as subconfluent cells in
the presence of DMOG. After 24 h, the area covered by
individual DMOG-treated cells was about 30% larger than
that of control cells (Additional file 2: Figure S2A/B).
DMOG leads to long-term alterations of F-actin structures
Treatment with DMOG over night markedly altered the
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Figure 1 DMOG alters cell-cell and cell-matrix interactions.
Spheroids of microvascular endothelial glEND.2 cells were generated
as described in Materials and Methods. Upon plating on collagen
IV-coated plates cells were treated with 1 mM DMOG for 24 h.
(A) Radial migration off the spheroids after 24 h was significantly
impaired by DMOG-treatment and more cells remained in the
residual spheroids. F-actin fibers were visualized with PromoFluor
phalloidin, nuclei were stained with Hoechst. Scale bar: 100 μm.
(B) For quantification at least 6 spheroids were analyzed and the
data of 7 independent experiments were summarized as means ±
SEM, **p < 0.01, one sample t-test. C: Control cells; D: DMOG-treated
cells; RS: area covered by residual spheroids; Area: area covered by
migrated cells; Cells: number of cells migrated off the spheroids.
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fibers, whereas DMOG-treated cells were characterized by
thick F-actin fibers oriented in parallel. When cells were
treated with DMOG for the last 6 h or 3 h of the migra-
tion period of 24 h, it became evident that 6 h were
needed to induce aligned F-actin fibers (Figure 2B). Aftertreatment for 3 h DMOG-treated cells still resembled
control cells, even though earlier experiments had shown
that HIF-1α was stabilized by DMOG within 1 h [29] and
rearrangement of F-actin fibers may occur within 1 h
upon stimulation with lysophosphatidic acid (data not
shown). These findings led to the hypothesis that re-
arrangement of F-actin fibers was not due to DMOG per
se, but required HIF-1α-dependent regulation of protein
synthesis. Treatment with DMOG not only increased the
area covered by individual cells but also led to gaps be-
tween individual cells, possibly reflecting the tension
within the cells due to the strong cell spanning F-actin fi-
bers (Arrow heads in Figure 2B, lower panels).
Treatment with DMOG markedly altered VE-cadherin
mediated cell-cell adhesions (Figure 2C). While linear dis-
tribution of VE-cadherin along the cell borders prevailed
in control cells, orthogonal orientation of VE-cadherin
was characteristic of DMOG-treated cells.
Within the spheroids the endothelial cells showed
peripheral F-actin fibers typical for cells cultured in three-
dimensional conditions (Figure 2D). DMOG-treated spher-
oids appeared more organized, as also shown by the
well-ordered VE-cadherin structures (Figure 2E). Nuclei
within the spheroids remained structurally intact and did
not show any signs of necrosis or apoptosis due to hypoxia
or shortage of nutrients (data not shown). DMOG also
modified the structural organization of spheroids when
added during the time of spheroid generation as hanging
drops. Spheroids obtained in the presence of DMOG
appeared more compact than control spheroids (Additional
file 3: Figure S3A/B).
Next, we compared the impact of DMOG on endothelial
cell morphology in cells migrating from spheroids with the
effects of DMOG on cells cultured as monolayers. DMOG
treatment of subconfluent cells, which had not established
firm interactions with other cells and the matrix, induced
formation of thick F-actin fibers (Additional file 2: Figure
S2B). Changes in cytoskeletal architecture were less obvious
when a confluent monolayer of cells was treated with
DMOG (Additional file 2: Figure S2C). These observations
indicated that in terms of morphological alterations
DMOG affected motile cells more strongly than firmly at-
tached cells.
Morphological alterations are HIF-1α dependent
The HIF-α isoforms HIF-1α and HIF-2α have been shown
to activate different target genes depending on the cellular
background [30]. To address the question which HIF-α iso-
form was responsible for the effects of DMOG, we gener-
ated glEND.2 cells with a stable knockdown of HIF-1α and
HIF-2α respectively (shHIF-1α and shHIF-2α). Successful
generation of those cell lines was demonstrated by knock-
down of HIF-α proteins, which were no longer stabilized














Figure 2 DMOG strengthens F-actin fibers and supports cell
structures within spheroids. (A) DMOG strongly affected
orientation of F-actin fibers in migrating cells treated with 1 mM
DMOG for 24 h. Compared to control cells, a regular pattern of
strong parallel F-actin fibers was observed (PromoFluor phalloidin
staining, confocal microscopy). Scale bar: 20 μm. (B) F-actin fibers
were still highly irregular when cells were treated with 1 mM DMOG
for the last 3 h only (DMOG -3 h), whereas treatment with DMOG
for the last 6 h induced alignment of F-actin fibers (DMOG -6 h).
Arrows indicate gaps between cells. Scale bar: 20 μm. (C) Cell-cell
contacts were visualized by staining of VE-cadherin after spheroids
were treated with 1 mM DMOG for 24 h. Scale bar: 20 μm. (D/E)
F-actin structures (D) and VE-cadherin (E) within the spheroids were
visualized by apotome technique. Cortical F-actin and VE-cadherin
formed distinct patterns in DMOG-treated cells. Scale bar: 20 μm.
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hypoxia induced mRNA expression of HIF target genes such
as phosphoglycerate kinase PGK and the glucose transporter
GLUT1 (Figure 3B). Both were regulated by HIF-1α as
shown by the reduced expression in shHIF-1α cells.
We then determined which HIF-α isoform was respon-
sible for the DMOG-dependent morphological alterations
of cells migrating from spheroids. F-actin staining of non-
stimulated shRNA knockdown cell lines did not differ sig-
nificantly from control cells (data not shown). Treatment
with DMOG strengthened F-actin structures in shHIF-2α
clones, but not in shHIF-1α clones, indicating a role
for HIF-1α in DMOG-mediated structural alterations
(Figure 3C). Concomitantly, DMOG increased the residual
spheroid area in GFP-transfected cells and in HIF-2α
knockdown cells, but not in cells with stable knockdown of
HIF-1α (Figure 3D). These results clearly demonstrated that
stabilization of residual spheroids and F-actin alterations by
DMOG were HIF-1α dependent.
Activity of Rho-kinases is necessary, but not sufficient for
DMOG-mediated stabilization of glEND.2 cells
Formation of intracellular stress fibers is largely regu-
lated by the activity of the small GTPase RhoA and
Rho kinases. To analyze the effect of a long lasting activa-
tion of RhoA signaling, constitutively active RhoA was
overexpressed in glEND.2 cells. Transfected cells formed a
dense network of fine F-actin fibers (Figure 4A). Due
to the poor transfectability of the microvascular endo-
thelial cells only few individual cells overexpressed
constitutively active RhoA and therefore, overexpression
of RhoA did not affect cell migration or spheroid size.
Cells overexpressing dominant negative RhoA (dnRhoA)
rounded, lost cell-cell contacts with neighboring cells and
detached, thus preventing further analysis of F-actin struc-
tures (data not shown). Therefore, we pharmacologically
inhibited Rho effectors, namely Rho-kinases by H1152,
which completely prevented the formation of F-actin stress
fibers and also reduced the size of the residual spheroids in
DMOG-treated cells (Figure 4B). Cells within the spheroids
appeared less tightly packed, suggesting a decrease in cell-
cell adhesions. We have shown earlier that inhibition of
Rho kinases increased directional motility of microvascular
endothelial cells, reflected among others in increased num-
bers of migrated endothelial cells from spheroids [19]. This
was also observed in the presence of DMOG: coincubation
with H1152 significantly increased the number of migrat-
ing cells (Figure 4C). This data provides evidence that Rho
kinase activity was necessary to maintain the DMOG-
induced morphological alterations, and also supported the
cell-cell adherence within the spheroid.
However, incubation of the cells with DMOG for 6 h led
to a moderate decrease in Rho kinase activity as determined




Figure 3 Morphological alterations induced by DMOG are HIF-1α dependent. (A) glEND.2 cells were stably transfected with shGFP, shHIF-1α
or shHIF-2α. The clones were cultured under normoxic (N) or hypoxic (H, 1% O2) conditions, or treated with DMOG (D, 1 mM) for 6 h. 30 μg
protein of cellular protein were loaded for the detection of HIF-1α, and nuclear extracts (20 μg protein) were used for the detection of HIF-2α.
(B) Stably transfected cells, shGFP (GFP), shHIF-1α (HIF1α) or shHIF-2α (HIF2α), were exposed to hypoxia for 20 h. Expression of HIF-target genes
phosphoglycerate kinase (PGK) and glucose transporter GLUT-1 mRNA was upregulated in shGFP and shHIF-2α clones but not in shHIF-1α clones.
RNA was detected by real time RT-PCR. Expression of PGK or GLUT-1 in GFP cells was set to 1 in each experiment. Data are means ± SD of 4 to 9
experiments. *** p < 0.001, ** p < 0.01 compared to shGFP cells, ANOVA with Tukey’s multiple comparison test. (C) Spheroids obtained form
glEND2 cells stably transfected with GFP, shHIF-1α or shHIF-2α were plated on fibronectin and treated with 1 mM DMOG for 24 h. Knockdown
of HIF-1α prevented formation of strong F-actin fibers as visualized with PromoFluor phalloidin in shHIF-1α clones. Representative images of
shHIF-1α or shHIF-2α cells are depicted. Scale bar: 20 μm. (D) To quantify the areas covered by residual spheroids, cells were stained with
Hoechst. Scale bar: 50 μm Areas were quantified in 2 independent experiments with at least 8 spheroids in each group. Data are summarized as
means ± SD; mean value of spheroids of control cells was set to 1 in each experiment; error bars of control values represent variability within one
experiment. ** p < 0.01; ANOVA with Dunnett’s multiple comparison test.
Weidemann et al. Cell Communication and Signaling 2013, 11:80 Page 5 of 16
http://www.biosignaling.com/content/11/1/80phosphatase target protein) (Figure 4D). A further decrease
of Rho kinase activity was observed after 24 h of treatment.
A comparable decrease in MYPT phosphorylation was de-
tected in shGFP and shHIF-2α transfected cells, whereas in-
hibition was significantly less pronounced in shHIF-1α
clones (Figure 4E). This indicated that inhibition of MYPT
phosphorylation by DMOG was regulated by HIF-1α.Taken together, these data revealed two aspects of
DMOG-mediated structural reorganization of endothelial
cells. On the one side, intact Rho kinase signaling is crit-
ical for the DMOG-mediated cytoskeletal alterations. On
the other hand, in the context of DMOG-induced inter-
ference with enzymes regulating actin structures Rho kin-





Figure 4 RhoA - Rho kinase signaling is active in DMOG-treated cells. (A) glEND.2 microvascular cells cultured in cell culture dishes were
transfected with constitutively active eGFP-V14-RhoA. After 24 h, cells were stained for F-actin. Transfected cells are characterized by high density
of F-actin fibers. Scale bar: 20 μm. (B) Spheroids were treated with DMOG (1 mM) or DMOG plus H1152 (0.75 μM) for 24 h. The Rho kinase
inhibitor reduced the size of the remaining spheroids and prevented stress fiber formation. Nuclei were stained with Hoechst, and F-actin fibers
with PromoFluor phalloidin. Scale bar upper panel: 100 μm; lower panel: 20 μm. (C) The number of cells migrated off spheroids was determined
in two independent experiments with at least 15 spheroids for each condition. Mean cell numbers (means ± SD) of control cells was set to 1,
error bars of control values represent variability within one experiment. ** p < 0.01 as indicated, *** p < 0.001 compared to respective controls, n.s:
not significant; ANOVA with Dunnett’s multiple comparison test. (D) Cells cultured in cell culture dishes were incubated with DMOG for 6 and
24 h. Phosphorylated MYPT was detected in cell culture homogenates by Western blotting. The blot is representative of three experiments.
(E) glEND2 cells stably transfected with GFP, shHIF-1α or shHIF-2α were cultured in cell culture dishes with (D) or without (C) DMOG for 24 h.
Phosphorylated MYPT was detected by Western blotting. For quantification, the ratio pMYPT/Vinc of non-treated cells was set to 1 at each
experimental condition (Co). ** p < 0.01, n = 3, means ± SD, ANOVA with Tukey’s multiple comparison test.
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dependent manner
Actin structures are largely dependent on the equi-
librium between activities of Rho and Rac GTPases. To
assess the role of Rac-1 activity in cells migrating out
of spheroids, Rac-1 localization was detected by im-
munocytochemistry. Lamellipodia of migrating en-
dothelial cells frequently showed Rac-1 colocalizing with
peripheral F-actin (Figure 5A, upper panel). In DMOG-
treated cells, Rac-1 was barely detectable at the periph-
ery (Figure 5A, lower panel). Therefore, we investigated
whether overexpression of dominant negative Rac-1
(dnRac-1) could mimic the changes in F-actin struc-
tures observed upon DMOG treatment. However, over-
expression of dnRac-1 resulted in apoptotic cell death,
as obvious by altered nuclear morphology (data not
shown). In contrast, overexpression of constitutively active
Rac-1 resulted in cells which were almost void of intracellu-
lar F-actin fibers (Figure 5B, upper panel). Moreover, con-
stitutively active Rac-1 co-localized with VE-cadherin at
the cell-cell junctions (Figure 5B, lower panel).
To circumvent the problem of poor transfectability
and cell death by dnRac-1, cells were treated with two
chemically distinct Rac inhibitors, EHT1864 and NSC23677,
which also differ in their molecular targeting [31,32]. Incu-
bation of spheroids with EHT1864 or NSC23677 induced
the formation of cell spanning F-actin fibers which resem-
bled those obtained in the presence of DMOG (Figure 5C).
Compared to DMOG, however, the thickness of the
fibers was reduced, in line with the notion that
DMOG-mediated stabilization of HIF-1α goes beyond
modulation of Rac-1. Pharmacological inhibition of
Rac-1 also increased the size of the residual spheroids in-
dicative of stabilization of cell-cell adhesions (Figure 5D).
In line with Rac-1 being located downstream of HIF, re-
sidual spheroids were increased in both, shHIF-1α
and shHIF-2α clones upon incubation with NSC23677
(Additional file 4: Figure S4). Rac-1, however, was not
a direct transcriptional target of HIF-α. Western blot
analysis of cells, which were freshly seeded and re-
acted to DMOG with morphological alterations, did
not alter Rac-1 expression as determined by Western
blotting (data not shown), indicative of regulation of
Rac-1 activity, but not Rac-1 protein. This was con-
firmed by direct assessment of the amount of GTP-
bound active Rac-1, which was downregulated after
overnight treatment with DMOG and remained in-
active upon seeding of the cells (Figure 5E).
PAK is inhibited by DMOG in a HIF-1α-dependent manner
To further delineate Rac-1 signaling, we analyzed the
expression and activation of endogenous activated p21-
activated kinase (PAK). PAK is directly activated by Rac-
1 and mediates many of its morphological effects inendothelial cells [33]. To quantify phosphorylated PAK,
Rac-1/PAK signaling was activated by cell adhesion.
Cells were incubated with DMOG over night and then
replated for 1 h. Phosphorylated endogenous PAK was
detectable in control cells and was downregulated in
DMOG-treated cells (Figure 6) Comparison of shHIF-
1α and shHIF-2α clones showed reduced PAK activity
in DMOG-treated cells only in shHIF-2α clones, which
indicated that HIF-1α was necessary for PAK regulation.
To confirm the role of HIF-1α in PAK inhibition and rule
out effects of chronic HIF-1α knockdown, HIF-1α was
transiently silenced by specific siRNA as described pre-
viously [29]. As expected, siHIF-1α inhibited DMOG-
mediated reduction of PAK phosphorylation (Figure 6,
right panel). Taken together, these results demonstrate
that functional HIF-1α is necessary for the inhibition of
phosphorylation of PAK by DMOG.
Morphological alterations in HUVEC upon incubation
with DMOG
Effects of DMOG were further investigated in human
primary umbilical vein endothelial cells (HUVEC), which
were organized into spheroids and were then treated with
DMOG. Control cells migrated off the spheroids which flat-
tened and lost their structure, whereas spheroids remained
organized in the presence of DMOG (Figure 7A/B). Repre-
sentative overviews of F-actin-stained cells are shown in
Figure 7A. A more detailed view of the structure within the
spheroids was obtained by apotome technique (Figure 7B).
Merged images projected on the z-axis revealed the differ-
ent height of the spheroids, which was obvious even after
fixation and staining. As observed with microvascular cells,
the number of cells which migrated off the spheroids
was significantly decreased upon treatment with DMOG
(Figure 7C). Migration of these cells was impaired as
the area covered was much smaller than in controls,
i.e. the migration distance of individual cells was re-
duced (Figure 7C). DMOG also altered the cytoskeletal
organization of HUVEC. Migrating control cells were
characterized by distinct F-actin fibers at the front of la-
mellipodia and cell spanning F-actin fibers (Figure 7D).
In contrast, DMOG-treated cells lacked extended la-
mellipodia, F-actin fibers were concentrated subcor-
tical with very little cell spanning fibers (Figure 7D).
Reorganization was also reflected by VE-cadherin dis-
tribution: VE-caderin was poorly visible in the peri-
phery of migrating control cells (Figure 7A) due to
the loose perpendicular structures observed at higher
magnification (Figure 7D). The tight cell-cell contacts
in DMOG-treated cells correlated with VE-cadherin
organized as distinct band along the cell boundaries
(Figure 7D). In contrast to microvascular cells we ob-
served increased levels of pMYPT upon incubation





Figure 5 (See legend on next page.)
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Figure 5 Rac-1 activity is reduced in DMOG-treated glEND.2 cells. (A) Spheroids were treated with 1 mM DMOG overnight. F-actin (red) and
VE-cadherin (green) were visualized by PromoFluor phalloidin staining and indirect immunofluorescence, respectively, using confocal microscopy.
Colocalization at the cell periphery of migrating cells was observed in control cells but not in DMOG-treated cells. Scale bar: 5 μm. (B) glEND.2
cells cultured in cell culture dishes were transfected with constitutively active eGFP-V12-Rac-1 coupled to GFP. Cells were analyzed after 24 h.
Overexpression of Rac-1 reduced F-actin stress fibers (upper panels). Rac-1 was concentrated at the cell borders as shown by colocalization with
VE-Cadherin (lower panels). Scale bar: 20 μm. (C) Spheroids were treated with DMOG (1 mM), EHT1864 (EHT, 5 μM) or NSC23677 (NSC, 100 μM)
for 24 h leading to strengthening of F-actin fibers. F-actin was visualized by PromoFluor phalloidin staining. Scale bar: 10 μm. (D) Residual
spheroid area was determined after 24 h in 3 independent experiments with 9–10 spheroids for each condition; mean value of spheroid areas in
control cells was set to 1 in each experiment; means ± SD *** p < 0.001 compared to control cells, Dunnett’s post hoc test. (E) glEND.2 cells
treated with DMOG (1 mM) were cultured in cell culture dishes over night and then were reseeded for 1 h. GTP-Rac was precipitated from
500 μg cellular protein. Total Rac was detected in 25 μg cellular protein. The ratios Rac-GTP/Rac (given between the blots) show a strong
decrease in samples treated with DMOG. The blot is representative of two independent experiments with a reduction of Rac-GTP > 80%.
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glEND.2 cells, Rac-1 activity was strongly reduced in
HUVEC exposed to DMOG (Figure 7F). Reduction of
Rac-1 activity thus increased cell-cell interactions in
both, glEND.2 cells and HUVEC, whereas cell matrix
interactions were modulated differentially in both cell
types, leading to more directional migration in glEND.2
cells and reduced migration in HUVEC.A
B
Figure 6 PAK phosphorylation is reduced by DMOG in a HIF-1α
dependent fashion. (A) glEND.2 cells were incubated with 1 mM
DMOG over night and were then replated for 45 to 60 min.
Endogenous phospho-PAK was detected by Western blotting.
Blots show representative experiments. (B) The graph depicts the
ratio phospho-PAK to vinculin detected in different experiments.
Downregulation of HIF-1α by shRNA or siRNA prevented DMOG-
mediated reduction of PAK phosphorylation as observed in control
cells or shHIF-2α clones. Value of control cells was set to 1 in each
experiment. glEND.2: n = 5, *** p < 0.001, two sided one sample
t-test; shHIF: n = 3, p < 0.05, Student’s t-test; siHIF: means ± half range
of two experiments.Discussion
In this study we show that inhibition of HIF prolylhydroxylases
(PHDs) by DMOG stabilizes HIF-1α, which resulted in re-
duced Rac-1 activity and markedly altered F-actin
structures. These alterations led to sustained cell-cell
interaction and reduced cell motility in endothelial
cells, microvascular glEND.2 cells and HUVEC (sum-
marized in Figure 8).
As sensors of oxygen tension, PHDs are important
regulators of various steps of angiogenesis. Most of their
effects can be attributed to their role in regulating the
stability of HIF transcription factors [5,34]. PHD inhibitors
such as DMOG stabilize both HIF-α isoforms, but also ac-
tivate HIF-independent pathways, for example NF-kB sig-
naling [9,34,35]. Using stably transfected glEND.2 cells,
our data clearly showed that HIF-1α was the main medi-
ator of the observed morphological alterations and neces-
sary for the underlying inhibition of Rac-1/PAK signaling
after inhibition of PHDs. These findings were further con-
firmed by transient inhibition of HIF-1α using siRNA,
which also prevented DMOG-mediated downregulation
of phosphorylated PAK. Interestingly, spheroids formed
by cells in which HIF-2α was downregulated by shRNA
were consistently smaller than those obtained from
shHIF-1α or shGFP clones. Moreover, these cells were less
tightly attached as shown upon processing for F-actin
staining, where they tended to roll away (see Figure 3D).
A tendency to reduced matrix adhesion was also reported
in immortalized endothelial cells obtained from lungs of
HIF-2α knockout mice [36]. These results suggest distinct
roles for HIF-1α and HIF-2α in microvascular endothelial
cell adhesion, and especially the effect of HIF-2α warrants
further investigation.
Incubation of spheroids with the PHD inhibitor
DMOG affected both, cells in three dimensional clusters
and migrating cells. Our in vitro model addressed two
aspects of endothelial cell interaction: homotypic cell-
cell interactions which prevailed within the spheroids
and determined the size of the three dimensional spher-




Figure 7 HUVEC are sensitive to DMOG. (A) HUVEC were organized into spheroids and plated on collagen IV-coated plates in the presence
or absence of 1 mM DMOG. F-actin and VE-cadherin were visualized by PromoFluor phalloidin staining and indirect immunofluorescence,
respectively. Scale bar: 20 μm. (B) F-actin structures within the spheroids were visualized by apotome technique. Scale bar: 20 μm. Images were
merged to show the height of the spheroids in z-axis. (D) Higher magnifications of F-actin fibers and VE-cadherin structures as shown in
(Figure 7A). Scale bar: 20 μm. (C) After 24 h, nuclei were stained with Hoechst and the number of migrated cells was counted using ImageJ.
Cell numbers were quantified in 35 spheroids of 5 different preparations. The graph summarizes the data of 20 spheroids of three different
isolates (means ± SD). The area covered by F-actin stained cells (means ± SD) was determined in 35 spheroids of 5 different isolates. In each
experiment the mean value of control spheroids was set to 1, error bars reflecting the variability within one experiment . *** p < 0.0001, Student’s
t-test. (E) HUVEC were cultured in cell culture dishes treated with DMOG (1 mM) for 6 and 24 h. Phosphorylated MYPT was detected by Western
blotting. Data are means ± SD of 3 experiments performed in duplicate. In each experiment the mean value of controls was set to 1, error bars of
controls reflecting variability of biological samples. ** p < 0.01, Student’s t-test. (F) HUVEC cultured in cell culture dishes were treated with DMOG
(1 mM) for 24 h. GTP-Rac was precipitated from 700 μg cellular protein. Total Rac was detected in 25 μg cellular protein. The blot is
representative of 2 precipitations.
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Figure 8 Schematic summary of DMOG-induced modulation of endothelial cells morphology. Incubation of the cells with DMOG prevents
PHD-dependent degradation of HIF-1α. Stabilized HIF-1α modulates gene expression, which, as shown in our studies, leads to reduced Rac-1
activity associated with alterations in cell morphology.
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plates. These aspects of spheroid migration are not in-
dependent, but potentially interrelated: strong cell-cell
interactions would be expected to prevent migration on
extracellular matrices, whereas loosening of cell-cell
contacts would favor movement of the cells out of the
spheroid. With regard to molecular mechanisms related
to these processes, we previously reported reduced
spheroid size and increased numbers of migrating
endothelial cells upon inhibition of Rho kinases which
altered cytoskeletal structures and gene expression [19].
By contrast, stabilization of HIF-1α was associated with
an inhibition of Rac-1 activity and an increased spher-
oid size indicative of enhanced cell-cell adhesion. In
HUVEC, DMOG not only increased adhesion within
the spheroids, but also in migrating cells associated
with a significant reduction in cell migration.
In the model system used here, the driving forces for
cell migration were the differences in adhesive strength
between cells within the spheroids and cell-matrix inter-
actions on the matrix-coated cover slips. Attachment of
the cells to the extracellular matrix, either collagen IV or
fibronectin, was stronger than cell-cell adhesion between
neighboring cells within spheroids. In this experimental
setting, microvascular cells migrated readily, whereas
they were barely mobile when firmly attached to the
substratum, i.e. in scratch wounding assays [19]. DMOG
induced strong F-actin fibers in the migrating micro-
vascular glEND.2 cells. The alteration of F-actin stress
fibers was observed primarily in migrating cells, not in
cells imbedded in a monolayer or within the spheroids.
This suggests that structural effects of PHD inhibitors willbe most prominent in the context of neovascularization,
with lesser effects on cells in intact vessels. Notably, as the
endothelial cells needed serum for survival, migrating and
adherent cells were exposed to the same soluble media-
tors, and were not activated by single stimuli. This model
system thus differs from other studies which analyzed
short term effects of angiogenic factors such as thrombin
or VEGF on endothelial cells in confluent monolayers
(summarized in [37]). Hypoxia-mediated transient alter-
ations in the F-actin cytoskeleton and a redistribution of
vimentin filaments have been reported in pulmonary
endothelial cells to occur within one hour [38]. In our ex-
periments, more than 3 h were necessary to induce
sustained morphological alterations, even though HIF-1α
was induced rapidly within 1 h in glEND.2 cells [29].
Within this time frame, no changes in F-actin structures
were detectable upon DMOG treatment. This suggested
that changes were driven by HIF-1α-dependent alterations
in gene expression rather than by rapid interactions be-
tween proteins. Stabilization of HIF-1α transcription fac-
tors by PHD inhibitors leads to a whole set of changes in
gene expression which mostly overlaps with those induced
by the exposure of cells to hypoxia [39].
Rho and Rac GTPases are interacting regulators of the
organization and dynamics of the actin cytoskeleton
[23,37]. Our data indicated that DMOG-mediated alter-
ations in cell migration and cytoskeletal remodeling were
primarily due to reduced Rac-1 signaling. In line with
our observations, Pankov et al. had previously described
that decreased Rac-1 activity switched cell migration
patterns of fibroblasts from random to directionally per-
sistent migration, a phenotype which was not observed
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lines of evidence indicated that Rac-1 signaling was
reduced downstream of HIF-1α: (a) stabilization of F-
actin fibers and increased residual spheroid size was
observed in control cells, but not in shHIF-1α cell
clones; (b) DMOG-mediated reduction of PAK activity
was less pronounced in shHIF-1α cells and (c), inhib-
ition of Rac-1 activity affected spheroid size also in
shHIF-1α cells. Long-term stabilization of HIF-1α by
inhibition of PHDs, which also mimics chronic hyp-
oxia, thus reduces Rac-1 signaling in endothelial cells.
This is in contrast to its role in short-term hypoxia,
where Rac-1 was reported to act upstream of HIF-1α
and was required for the induction of HIF-1α protein
expression and transcriptional activity [41]. Physiologic-
ally, our observations are reminiscent of the in vivo piglet
model of hypoxia-induced neonatal pulmonary hyperten-
sion. Lung endothelial cells obtained from these animals
also showed reduced Rac-1 activity and increased F-actin
stress fibers [23].
As shown in detailed studies, Rho GTPases are impli-
cated in a complex network of regulatory proteins the
interaction of which is dependent on the cellular context
and the mode of activation or inhibition [42-44]. As
obvious examples for this diversity we observed different
regulation of MYPT phosphorylation in glEND.2 cells and
HUVEC with reduction of MYPT phosphorylation in
glEND.2 cells and a slight increase in HUVEC. Further-
more, both cell types also differed in their arrangement of
F-actin fibers, being primarily cortical in DMOG-treated
HUVEC and cell spanning in glEND.2 cells. More detailed
studies are warranted to dissect the spatio-temporal regu-
lation of actin-modulating proteins and their impact on
cell motility in both cell types.
Our model system not only addressed effects of PHD
inhibition on migrating endothelial cells, but also on
endothelial cells organized in three dimensional spheroids.
DMOG increased spheroid size in a HIF-1α-dependent
fashion, indicating strengthened cell-cell contacts as also
shown by strong VE-cadherin lining at the cell borders.
As shown by different pharmacological inhibitors, reduced
Rac-1 activity promoted stabilization of spheroids. These
data seem to be in contrast to other reports which show
that activation of Rac-1 is needed to promote stability of
endothelial barriers [22]. The discrepancy may be due to
substantial differences in experimental design. As outlined
above, inhibition of PHDs did not reduce the cellular con-
tent of Rac-1 proteins as seen in cells transfected with
dominant negative Rac-1 [45,46]. Furthermore, inhibition
of Rac-1 activity occurred over an extended time and thus
differed from rapid and more drastic alterations studied
in other model systems. Comparison of DMOG and the
inhibitors of Rac-1 activity, EHT1864 and NSC2367,
showed more pronounced effects of DMOG compared tothe inhibitors. This indicated that the stabilizing effect of
DMOG was not limited to the inhibition of Rac-1 activity,
but involved additional molecular mediators, which re-
main to be elucidated. Stabilization of endothelial cell-cell
interactions was in line with in vivo data obtained by
Mazzone et al. [7]. They observed normalization of tumor
vessel formation in PHD2 +/− mice, a model system with
only a partial reduction in PHD activity. Tumor vessel
normalization was related to less tumor invasiveness and
less metastasis [47], consistent with stabilization of endo-
thelial cell interactions. In summary our data provides evi-
dence that pharmacological inhibition of PHDs alters cell-
cell adhesion and cell motility in endothelial cells through
HIF-1α- and Rac-1-dependent pathways.
Conclusions
PHD inhibitors provide a novel therapeutic opportunity to
reduce ischemia-reperfusion injury in various organs
[48,49]. The beneficial effects include amelioration of blood
flow [17,50] and reduction of ischemic damage, which can-
not be attributed to single cell types but have to involve dif-
ferent cellular compartments including endothelial,
parenchymal and immune cells. Our in vitro data provide
the first evidence that PHD inhibitors support vascular
endothelial cell stability through HIF-1α dependent cyto-
skeletal reorganizations and thus may contribute to vessel
normalization and improved blood supply.
Methods
Cell culture
The murine glomerular microvascular endothelial cell
line (glEND.2) was kindly provided by R. Hallmann
(Muenster, Germany). Cells were characterized by posi-
tive staining for typical endothelial cell markers MECA-
32 and CD-31, and the lack of staining of mesangial cell
markers such as α-smooth muscle actin and α8-integrin,
as well as epithelial cell markers such as WT-1 and
cytokeratin [51]. Cells were cultured at 37°C and 7.5%
CO2 in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% FCS and routinely split in a 1:5 ratio as
described previously [29]. Cells were cultured under
hypoxic conditions in an incubator with 1% O2, 5% CO2
and balance nitrogen. Human umbilical vein endothelial
cells (HUVEC) were isolated and cultured as described
[52]. Isolation of human cells was approved by the local
ethics committee (approval number #3759) and written
consent was obtained from all donors.
Generation of stable HIF-1α and HIF-2α knockdown
glEND.2 cells
glEND.2 cells were stably transfected with shRNA producing
constructs by lentiviral infection. Lentiviral particles were
produced by transfecting HEK 293 T packaging cells (ATCC)
simultaneously with Pax2 plasmid, PMD2 plasmid (both
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using FuGene transfection reagent (Roche) in OptiMEM
medium (Life Technologies). 24 h after transfection, super-
natant containing lentiviral particles were collected, filtered
through a 45 μm syringe filter and added directly to
subconfluent glEND.2 cells. After 24 h, cells were washed
and cultured with selection medium containing puromycin
(Sigma) at a final concentration of 2.5 μg/ml. Knock-
down efficiency was controlled by Western blot analysis
of HIF-α protein expression and by quantitative real-time
PCR of classical HIF-α target genes such as phosphoglycer-
ate kinase (PGK) and glucose transporter 1 (GLUT-1).
Migration assays
Cell spheroids (400 cells per spheroid) were created
using the hanging drop method [29,53]. In brief, cells
were suspended in DMEM with 0.24% methylcellulose.
Cell suspension drops (400 cells/25 μl) were deposited
onto the underside of the lid of a tissue culture dish.
The lid was inverted and incubated overnight at 37°C.
For the spheroid migration assay, single spheroids were
deposited separately on fibronectin-coated glass plates
and stimulated as described in the Results section. F-actin
and nuclei were stained for quantification purposes to de-
termine area of residual spheroids, area and cell number
of migrated spheroids of at least 5 spheroids per experi-
mental group using ImageJ software. Live cell imaging was
performed as described [19].
Western blot analysis
Western blot analyses were performed by standard pro-
cedures as described previously [19]. Cells were cultured
as monolayers in cell culture dishes. To detect phospho-
PAK or phospho-MYPT, cells were lysed in SDS containing
buffer. For HIF-α, cell lysates were prepared in a urea
containing buffer [54]. To detect HIF-1α 30 μg of total pro-
tein was loaded. Nuclear extracts of glEND.2 clones were
prepared as described [6] and 20 μg protein analyzed for
HIF-2α expression.
The following antibodies were used: mouse anti-vinculin
(SC-5573), mouse anti-RhoA (SC-418) and peroxidase-
conjugated donkey anti-goat IgG (SC-2020), goat anti-
rat IgG (SC-2006) from Santa Cruz; mouse anti-Rac-1
(610651) from BD Transduction Laboratories; rabbit
anti-phospho-PAK (2601) and rabbit anti-phospho-
MYPT (Thr853) (#4563) from Cell Signaling, rabbit
anti-HIF-1α (NB100-449, Novus Biologicals), goat anti-
HIF-2α (AF2997, R&D Systems), rat anti-VE-cadherin
(14–1441, eBiosciences), mouse anti β–actin; sheep anti-
mouse IgG (NA931V), anti-rat donkey anti-rabbit IgG
(NA934V) from Amersham Biosciences.
Immunoreactive proteins were visualized by the en-
hanced chemiluminescence detection system (ECL-Plus,
Amersham). Immunoreactive bands were quantifiedusing the luminescent image analyzer (LAS-1000 Image
Analyzer, Fujifilm) and AIDA 4.15 image analyzer soft-
ware (Raytest). To correct for equal loading and blot-
ting, all blots were redetected with antibodies directed
against vinculin or β-actin. For quantification purposes,
the ratio of the specific protein band and a control pro-
tein was calculated.
Quantitative Real-Time PCR
Total RNA was isolated from glEND.2 cells after incuba-
tion with 1% oxygen for 18 h using RNeasy kit (Qiagen)
according to the manufacturer’s protocol. First-strand syn-
thesis was performed with 1 μg of total RNA with the
MaximaTM First Strand cDNA synthesis kit (Fermentas)
according to the manufacturer’s recommendations. cDNAs
were amplified in SYBR Green MaximaTM Master Mix
(Fermentas) with a StepOne PlusTM Real Time-PCR sys-
tem (Applied Biosystems). Expression levels were related
to 18 s using the delta-ct method. Primer sequences are as






Immunocytochemistry of glEND.2 cells was performed
essentially as described [19]. Primary antibodies were
those used for Western blotting. Secondary antibodies
(1:500, PromoFluor Fluor® 488 anti-mouse A21202 or
488 anti-rat A11006) were from Molecular Probes. F-
actin was stained with PromoFluor 488 or 555 phalloidin
from PromoKine, nuclei were visualized with Hoechst
(Sigma-Aldrich). After mounting, slides were viewed
using a Nikon fluorescence microscope. Digital images
were recorded using Spot imaging software (Diagnostic
Instruments). Co-localization of proteins was confirmed
by confocal microscopy using a Zeiss LSM 710 scanning
unit equipped with an Argon laser, a HeNe 633 laser and
a DPSS 561–10 laser on an Axio Observer Z1 inverted
microscope. To avoid spectral crosstalk between the used
fluorochromes and to sustain high sensitivity scanning
was performed in two sequential scanning steps.
All stainings shown are representative of at least 3 inde-
pendent experiments. ImageJ software was used to quan-
tify cell numbers and areas covered by spheroids or cells.
Transfection - siRNA Transfection
To down-regulate HIF-1α expression, endothelial cells
(glEND.2) were transfected with the specific siRNAs
(50 nM) 3 h after seeding using HiPerFect (QIAGEN)
according to the manufacturer’s instructions. Specific
siRNAs directed against HIF-1α (sense 5′-GCC-ACU-
UCG-AAG-UAG-UGC-U), or an irrelevant siRNA (5′-
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from Eurogentec. Experiments were performed 48 h after
transfection.
DNA transfection
Cells were seeded on collagen IV-coated cover slips at
low density (12,500 cells/cm2). The next day, cDNA
constructs encoding constitutively active Rac-1 (human
pEGFP/Rac1(V12)) or RhoA (human pEGFP/RhoA(V14))
were transfected using X-treme HD (Roche) following the
manufacturer’s instructions.
Determination of Rac-1 activity
Rac-1 activity was determined essentially as described pre-
viously [55]. The GTP-bound form of Rac-1 was recov-
ered from 500 μg of cell lysate by affinity precipitation
using a GST-fusion protein carrying the Rac-1 binding do-
main of PAK1B as an activation-specific probe for en-
dogenous Rac-1 [56].
Data analysis
Data are presented as means ± s.d or s.e.m. of n > 3 inde-
pendent experiments as detailed in the legends. To com-
pare two samples, Student’s t-test or one sample t-test was
used. ANOVA with Tukey Kramer multiple comparison
or Dunnett’s post hoc test was used to compare multiple
measurements (Prism GraphPad Software, La Jolla, CA,
USA). A p value < 0.05 was considered significant.
Materials
Cell culture materials were purchased from PAA
Laboratories. The following biochemicals were used:
H1152, (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sul-
fonyl]-homopiperazine, (Alexis Biochemicals), collagen-IV
(Sigma), fibronectin (BD Bioscience); methylcellulose
4000 (Fluka); dimethyloxalyl glycine (DMOG, Cayman
Chemical). Two Rac-1 inhibitors were used: EHT1864
(Tocris), which places Rac-1 in an inert and inactive
state [32] and NSC23677 (Calbiochem), which specif-
ically inhibits Rac-1 GDP/GTP exchange activity [31].
Additional files
Additional file 1: Live cell imaging of glEND.2 cells. Spheroids of
glEND.2 cells were plated on collagen IV-coated glass plates and treated
with or without DMOG (1 mM). Movement of cells was monitored with
an inverted microscope (Leica DMI3000B) in phase contrast mode using
a 20x 0.4 NA objective with a 0.5x video coupler. The microscope was
equipped with an incubation chamber to maintain the spheroids at 37°C
and 7.5% CO2. 200 images were taken every 5 min for 17 h.
Additional file 2: Figure S2: DMOG-mediated structural alterations
in low-density glEND.2. (A) glEND.2 cells were seeded at low density on
fibronectin-coated glass plates and incubated for 24 h with or without
1 mM DMOG. Cells were visualized by staining F-actin with PromoFluor
phalloidin and staining of nuclei with Hoechst. In each condition, 6 visual
fields were randomly chosen, the number of cells was counted and thearea covered by the cells determined using ImageJ software. The graph
depicts area per cell in arbitrary units, means + SD of 6 fields. ** p < 0.01,
Student’s t-test. (B) glEND.2 cells were seeded at low density on
fibronectin–coated glass plates and incubated for 24 h with or without
1 mM DMOG. F-actin fibers were visualized by PromoFluor phalloidin
staining. DMOG-treated cells showed strong F-actin fibers and appeared
more spread. Scale bar: 20 μm. (C) glEND.2 cells were seeded to form a
confluent monolayer and then incubated with DMOG for 24 h. F-actin
fibers were visualized by PromoFluor phalloidin staining. Scale bar:
20 μm.
Additional file 3: Figure S3: Generation of spheroids in the
presence of DMOG. (A) Spheroids were generated by the hanging drop
method in the presence or absence of DMOG. For quantification,
spheroids were allowed to adhere on plates for 3 h. Spheroids with
DMOG appeared more tightly packed forming round structures
compared to the control spheroids which appeared less organized.
Accordingly, the area covered by DMOG-treated spheroids was reduced.
The graph summarizes data (means + SD) of 30 spheroids of three
different experiments. In each experiment the mean value of control
spheroids was set to 1, error bars reflect the variability within one
experiment. *** p < 0.001, Student’s t-test. (B) After fixation the nuclei
were stained with DAPI to assess the height of the spheroids by
apotome technique. Layers were merged and the height of the spheroid
approximated by the fluorescence of the z-axis. Data of 6 spheroids each
of one representative experiment are depicted. *** p < 0.001, Student’s
t-test.
Additional file 4: Figure S4: Inhibition of Rac-1 is effective
independently of HIF. Spheroids of shHIF-1 and shHIF-2 clones were
treated with 100 μM NSC23677 overnight. The area covered by residual
spheroids was determined in 6 spheroids for each condition. Mean value
of control cells was set to 1. * p < 0.05, Student’s t-test. The Rac-1 inhibitor
increased spheroid size independently of HIF-1 or HIF-2 knockdown. Scale
bar: 20 μm.
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